Category:Bcr-Abl inhibitors

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Drugs that inhibit Bcr-Abl, the constitutively active tyrosine kinase resulting from the Philadelphia chromosome 9:22 translocation seen in chronic myelogenous leukemia (CML) and some acute lymphocytic leukemias (ALL).


This category has only the following subcategory.

Pages in category "Bcr-Abl inhibitors"

The following 8 pages are in this category, out of 8 total.